CTNNB1 codon(s) 32, 33, 34, 35, 36, 37, 41, 45 any
Somatic mutations in CTNNB1 occur in about 1-4% of lung adenocarcinoma. No real progress has been made in targeting oncogenic mutant forms of CTNNB1 in lung cancer.
Greulich. The Genomics of Lung Adenocarcinoma: Opportunities for Targeted Therapies. Genes & Cancer 1(12) 1200–1210
Disclaimer: You assume full responsibility for all risks associated with using this PMKB website. The IPM makes no guarantee of the comprehensiveness, reliability or accuracy of the information on this website and the IPM assumes no responsibility for errors in the information associated with this web site. Healthcare providers and patients must integrate all clinical and laboratory findings as well as information from a variety of sources before deciding on appropriate clinical care options.